{"transactions":[{"id":1161359,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":80217,"kind":"person","name":"Audet Juliette Berangere","position":1,"cik":"0002000393","reported_name":"Audet Juliette Berangere","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Option (right to buy)","published_at":"2025-05-02T16:56:15.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on May 1, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":20.03,"expiration_date":"2035-05-01","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-062897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000393/000095017025062897/ownership.xml","form_type":"4"}},{"id":1308388,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":80217,"kind":"person","name":"Audet Juliette Berangere","position":1,"cik":"0002000393","reported_name":"Audet Juliette Berangere","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-07T17:15:41.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2025 for no consideration."}],"balance_after":15104,"source":{"system":"sec-edgar","filing":"0000950170-25-002996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000393/000095017025002996/ownership.xml","form_type":"4"}},{"id":1311192,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":80217,"kind":"person","name":"Audet Juliette Berangere","position":1,"cik":"0002000393","reported_name":"Audet Juliette Berangere","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option (right to buy)","published_at":"2025-01-06T17:54:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through such date."}],"balance_after":100000,"derivative":{"exercise_price":25.96,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-002370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000393/000095017025002370/ownership.xml","form_type":"4"}},{"id":1397993,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":80217,"kind":"person","name":"Audet Juliette Berangere","position":1,"cik":"0002000393","reported_name":"Audet Juliette Berangere","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-30T17:22:34.000Z","date":"2024-09-26","kind":"purchase","planned":false,"acquired":true,"shares":1104,"price":15.7,"value":17332.8,"ownership":{"direct":true},"balance_after":1104,"source":{"system":"sec-edgar","filing":"0000950170-24-110440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000393/000095017024110440/ownership.xml","form_type":"4"}},{"id":1554056,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":80217,"kind":"person","name":"Audet Juliette Berangere","position":1,"cik":"0002000393","reported_name":"Audet Juliette Berangere","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option (right to buy)","published_at":"2024-04-02T16:30:15.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person resigned from the Issuer's board of directors, effective April 1, 2024, in light of her appointment as the Issuer's Chief Business Officer (\"CBO\"). The option reported herein was granted in connection with the Reporting Person's appointment as CBO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying the option will vest on April 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":250000,"derivative":{"exercise_price":21.37,"expiration_date":"2034-04-01","underlying":"Ordinary Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-24-040235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000393/000095017024040235/ownership.xml","form_type":"4"}}]}